Shred Weight loss

Shred Weight Loss operates as a telehealth-focused medical weight loss clinic serving patients in Arizona and Utah, with lead provider Logan Linarte, PA-C, overseeing all clinical care. The practice centers exclusively on GLP-1 receptor agonist therapy for weight management, offering both semaglutide and tirzepatide as prescription options for eligible patients. Based in Mesa, AZ, the clinic conducts all consultations remotely, eliminating the need for in-person visits while maintaining full medical oversight and ongoing patient monitoring throughout treatment.

The clinic's treatment protocol revolves around two FDA-approved GLP-1 medications: semaglutide, which mimics the incretin hormone to regulate appetite and glucose metabolism, and tirzepatide, a dual GIP/GLP-1 receptor agonist that targets both incretin pathways for enhanced metabolic effect. Logan Linarte evaluates each patient's medical history, current health status, and weight loss objectives during the initial telehealth consultation to determine appropriate medication selection and starting dosage. Prescriptions are fulfilled through Strive Pharmacy, the clinic's designated compounding partner, which prepares and ships medications directly to patients in Arizona and Utah. Dose adjustments follow established titration schedules, with Linarte monitoring patient response, tolerance, and progress through follow-up virtual appointments.

Logan Linarte brings physician assistant training and certification to the practice, focusing clinical expertise specifically on obesity medicine and metabolic health management. As a PA-C, Linarte operates under collaborative physician oversight while maintaining primary responsibility for patient assessment, prescription management, and treatment modification. The clinic's approach emphasizes individualized dosing strategies, with Linarte addressing patient questions about injection technique, side effect management, and realistic weight loss timelines during ongoing telehealth check-ins. Patients receive guidance on coordinating GLP-1 therapy with exercise routines and nutritional adjustments, though the primary clinical intervention remains pharmacological rather than comprehensive lifestyle programming.

The patient experience at Shred Weight Loss begins with an online intake process where individuals complete medical questionnaires detailing health history, current medications, previous weight loss attempts, and treatment goals. Following chart review, Logan Linarte conducts a live video consultation to discuss candidacy for semaglutide or tirzepatide, explain expected outcomes, review potential adverse effects including gastrointestinal symptoms, and establish a monitoring schedule. Patients approved for treatment receive their first prescription, which Strive Pharmacy compounds and delivers within days. Subsequent appointments occur at intervals aligned with dose escalation protocols, typically every four weeks during the titration phase, with Linarte available between scheduled visits to address concerns about dosing, pain at injection sites, or unexpected reactions.

Shred Weight Loss differentiates itself through its streamlined telehealth model that removes geographic barriers for Arizona and Utah residents seeking medical weight loss care without the time commitment of traditional clinic visits. The practice maintains a 5.0-star rating across 25 Google reviews, with patients frequently noting the accessibility of care, responsiveness to questions, and effectiveness of both semaglutide and tirzepatide in achieving weight loss goals. The clinic's partnership with Strive Pharmacy ensures consistent medication supply and quality compounding standards, while the telehealth-only structure allows Logan Linarte to manage a patient panel across two states from the Mesa headquarters. This model serves individuals who prefer remote medical consultations and are comfortable with self-administered subcutaneous injections as their primary weight management intervention.